Evaluation of E-cadherin in the prediction of liver metastasis of colorectal carcinoma
Han Liang
Abstract
Han Liang
Abstract
Objective: To investigate the abnormal expression of E-cadherin in colorectal carcinoma and its correlation with liver metastasis of colorectal carcinoma. Methods: The abnormal expression of E-cadherin was detected using immunohistochemical methods in 30 colorectal carcinoma tissues without liver metastasis,30 with synchronal liver metastasis,30 with heterochronia liver metastasis and 30 surrounding normal colorectal tissues. Results:(1)The abnormal expression of E-cadherin in colorectal carcinoma was significantly higher than that in surrounding normal colorectal tissue (P0.05); The abnormal expression of E-cadherin in colorectal carcinoma was related to depth of invasion,lymph node metastasis and Dukes stages(P0.05). (2) The abnormal expression of E-cadherin in colorectal carcinoma with synchronal or heterochronia liver metastasis was significantly higher than that in tissues without liver metastasis(P0.05). Conclusion: E-cadherin may play a role in the process of developing hepatic metastasis. The abnormal expression of E-cadherin in colorectal carcinoma may be considered as a new clinical indicator for monitor of hepatic metastasis and prognosis of colorectal carcinoma.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To investigate the abnormal expression of E-cadherin in colorectal carcinoma and its correlation with liver metastasis of colorectal carcinoma. Methods: The abnormal expression of E-cadherin was detected using immunohistochemical methods in 30 colorectal carcinoma tissues without liver metastasis,30 with synchronal liver metastasis,30 with heterochronia liver metastasis and 30 surrounding normal colorectal tissues. Results:(1)The abnormal expression of E-cadherin in colorectal carcinoma was significantly higher than that in surrounding normal colorectal tissue (P0.05); The abnormal expression of E-cadherin in colorectal carcinoma was related to depth of invasion,lymph node metastasis and Dukes stages(P0.05). (2) The abnormal expression of E-cadherin in colorectal carcinoma with synchronal or heterochronia liver metastasis was significantly higher than that in tissues without liver metastasis(P0.05). Conclusion: E-cadherin may play a role in the process of developing hepatic metastasis. The abnormal expression of E-cadherin in colorectal carcinoma may be considered as a new clinical indicator for monitor of hepatic metastasis and prognosis of colorectal carcinoma.
Key concepts: Metastasis, Colorectal cancer, Medicine, Immunohistochemistry, Cadherin, Carcinoma, Lymph node metastasis, Oncology